Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line.


Journal

Cell biology and toxicology
ISSN: 1573-6822
Titre abrégé: Cell Biol Toxicol
Pays: Switzerland
ID NLM: 8506639

Informations de publication

Date de publication:
08 2019
Historique:
received: 10 10 2018
accepted: 29 11 2018
pubmed: 9 1 2019
medline: 21 7 2020
entrez: 9 1 2019
Statut: ppublish

Résumé

Scorpion venom, considered as a treasure trove of various bioactive molecules, is a new approach to induce cancer cell death via apoptosis pathways. In the present study, we evaluated for first time the anti-proliferative efficacy of Hemiscorpius lepturus scorpion venom and its pathway on a colon carcinoma cell. The CT26 and VERO cell lines were treated with various concentrations of the venom. The IC50 values were estimated by MTT assay test, and the apoptosis was evaluated by flow cytometry. Moreover, RT-PCR analysis was used to investigate the levels of Bax, Bcl2, Trp53, and Casp3 mRNA expression. The mice xenograft model was established to evaluate the therapy efficiency of venom. Some valuable exponential growth parameters were evaluated in treated mice. The scorpion venom inhibited the growth of CT26 cells with an IC50 value about 120 μg/ml. However, VERO cells increased to 896 μg/ml under the same condition. A remarkable apoptotic cells in CT26 cells were revealed by flow cytometry assay. A significant over-expression was observed in Bax, Casp3, and Trp53 and downregulated in Bcl2 mRNA level in tumor tissue after treatment with scorpion venom (p < 0.05). All changes of valuable exponential growth parameters showed a shrinking tumor size. Our findings indicated that Hemiscorpius lepturus venom has a special anti-proliferative effect on CT26 cells via Trp53/Bcl2/Casp3 pathway. Considering its powerful cytotoxic vigor against a colon cancer cell (CT26) and low toxicity to non-tumorigenic cell (VERO), we propose that this venom probably has a specific effect on other colon cancer cells and may turn out to be a novel therapeutic strategy in treating colon cancer.

Identifiants

pubmed: 30617443
doi: 10.1007/s10565-018-09455-3
pii: 10.1007/s10565-018-09455-3
doi:

Substances chimiques

Proto-Oncogene Proteins c-bcl-2 0
Scorpion Venoms 0
Tumor Suppressor Protein p53 0
bcl-2-Associated X Protein 0
Caspase 3 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-385

Auteurs

Mohammadreza Moradi (M)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran.

Rezvan Najafi (R)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran.

Razieh Amini (R)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran.

Reza Solgi (R)

Legal Medicine Research Center, Legal Medicine Organization of Iran, Hamadan, Iran.
Felestin Square, General Office of Legal Medicine, Ghobare Hamadani Blvd, Hamadan, 65187-53141, Iran.

Hamid Tanzadehpanah (H)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran.

Alireza Monsef Esfahani (AM)

Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran.
Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran.

Massoud Saidijam (M)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. sjam110@yahoo.com.
Hamadan University of Medical Sciences, Pejohesh Crossroads, Hamadan, 65178-38678, Iran. sjam110@yahoo.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH